118 related articles for article (PubMed ID: 32502493)
1. MUC16 C-terminal binding with ALDOC disrupts the ability of ALDOC to sense glucose and promotes gallbladder carcinoma growth.
Fan K; Wang J; Sun W; Shen S; Ni X; Gong Z; Zheng B; Gao Z; Ni X; Suo T; Liu H; Liu H
Exp Cell Res; 2020 Sep; 394(1):112118. PubMed ID: 32502493
[TBL] [Abstract][Full Text] [Related]
2. MUC16 C terminal-induced secretion of tumor-derived IL-6 contributes to tumor-associated Treg enrichment in pancreatic cancer.
Fan K; Yang C; Fan Z; Huang Q; Zhang Y; Cheng H; Jin K; Lu Y; Wang Z; Luo G; Yu X; Liu C
Cancer Lett; 2018 Apr; 418():167-175. PubMed ID: 29337110
[TBL] [Abstract][Full Text] [Related]
3. MiR-139-5p is associated with poor prognosis and regulates glycolysis by repressing PKM2 in gallbladder carcinoma.
Chen J; Yu Y; Chen X; He Y; Hu Q; Li H; Han Q; Ren F; Li J; Li C; Bao J; Ren Z; Duan Z; Cui G; Sun R
Cell Prolif; 2018 Dec; 51(6):e12510. PubMed ID: 30105813
[TBL] [Abstract][Full Text] [Related]
4. Carboxyl-terminal polypeptide fragment of MUC16 combing stathmin1 promotes gallbladder cancer cell migration and invasion.
Fan K; Zhang D; Li M; Shen S; Wang J; Ni X; Gong Z; Zheng B; Gao Z; Ni X; Suo T; Liu H; Liu H
Med Oncol; 2020 Nov; 37(12):114. PubMed ID: 33196934
[TBL] [Abstract][Full Text] [Related]
5. Suppression of fructose-bisphosphate aldolase C expression as a predictor of advanced oral squamous cell carcinoma.
Li YJ; Huang TH; Hsiao M; Lin BR; Cheng SJ; Yang CN; Lai WT; Wu TS; Fan JR; Kuo MY; Chang CC
Head Neck; 2016 Apr; 38 Suppl 1():E1075-85. PubMed ID: 26565993
[TBL] [Abstract][Full Text] [Related]
6. HASPIN is involved in the progression of gallbladder carcinoma.
Zhu D; Gu X; Lin Z; Yu D; Wang J; Li L
Exp Cell Res; 2020 May; 390(2):111863. PubMed ID: 31987787
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of aldolase, fructose-bisphosphate C and its association with spheroid formation in colorectal cancer.
Maruyama R; Nagaoka Y; Ishikawa A; Akabane S; Fujiki Y; Taniyama D; Sentani K; Oue N
Pathol Int; 2022 Mar; 72(3):176-186. PubMed ID: 35147255
[TBL] [Abstract][Full Text] [Related]
8. Fibronectin promotes cell proliferation and invasion through mTOR signaling pathway activation in gallbladder cancer.
Cao Y; Liu X; Lu W; Chen Y; Wu X; Li M; Wang XA; Zhang F; Jiang L; Zhang Y; Hu Y; Xiang S; Shu Y; Bao R; Li H; Wu W; Weng H; Yen Y; Liu Y
Cancer Lett; 2015 May; 360(2):141-50. PubMed ID: 25657110
[TBL] [Abstract][Full Text] [Related]
9. PLEK2 promotes gallbladder cancer invasion and metastasis through EGFR/CCL2 pathway.
Shen H; He M; Lin R; Zhan M; Xu S; Huang X; Xu C; Chen W; Yao Y; Mohan M; Wang J
J Exp Clin Cancer Res; 2019 Jun; 38(1):247. PubMed ID: 31182136
[TBL] [Abstract][Full Text] [Related]
10. MUC16 promotes EOC proliferation by regulating GLUT1 expression.
Wang F; Zhang Q; Zhang H; Qiao X; Zhang X; Zhang K; Gu X; Wang L; Cui J
J Cell Mol Med; 2021 Mar; 25(6):3031-3040. PubMed ID: 33543559
[TBL] [Abstract][Full Text] [Related]
11. Prohibitin overexpression predicts poor prognosis and promotes cell proliferation and invasion through ERK pathway activation in gallbladder cancer.
Cao Y; Liang H; Zhang F; Luan Z; Zhao S; Wang XA; Liu S; Bao R; Shu Y; Ma Q; Zhu J; Liu Y
J Exp Clin Cancer Res; 2016 Apr; 35():68. PubMed ID: 27084680
[TBL] [Abstract][Full Text] [Related]
12. MUC16-mediated activation of mTOR and c-Myc reprograms pancreatic cancer metabolism.
Shukla SK; Gunda V; Abrego J; Haridas D; Mishra A; Souchek J; Chaika NV; Yu F; Sasson AR; Lazenby AJ; Batra SK; Singh PK
Oncotarget; 2015 Aug; 6(22):19118-31. PubMed ID: 26046375
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of AMPK/PFKFB3 mediated glycolysis synergizes with penfluridol to suppress gallbladder cancer growth.
Hu J; Cao J; Jin R; Zhang B; Topatana W; Juengpanich S; Li S; Chen T; Lu Z; Cai X; Chen M
Cell Commun Signal; 2022 Jul; 20(1):105. PubMed ID: 35842652
[TBL] [Abstract][Full Text] [Related]
14. miR-365 inhibits the progression of gallbladder carcinoma and predicts the prognosis of Gallbladder carcinoma patients.
Jiang ZB; Ma BQ; Feng Z; Liu SG; Gao P; Yan HT
Cell Cycle; 2021 Feb; 20(3):308-319. PubMed ID: 33459111
[TBL] [Abstract][Full Text] [Related]
15. Aldolase A promotes proliferation and G
Fu H; Gao H; Qi X; Zhao L; Wu D; Bai Y; Li H; Liu X; Hu J; Shao S
Cancer Commun (Lond); 2018 May; 38(1):18. PubMed ID: 29764507
[TBL] [Abstract][Full Text] [Related]
16. CA125/MUC16 interacts with Src family kinases, and over-expression of its C-terminal fragment in human epithelial cancer cells reduces cell-cell adhesion.
Akita K; Tanaka M; Tanida S; Mori Y; Toda M; Nakada H
Eur J Cell Biol; 2013; 92(8-9):257-63. PubMed ID: 24246580
[TBL] [Abstract][Full Text] [Related]
17. Ubiquitin-specific protease 3 facilitates cell proliferation by deubiquitinating pyruvate kinase L/R in gallbladder cancer.
Liang RP; Zhang XX; Zhao J; Zhu RT; Wang WJ; Lu QW; Sun YL
Lab Invest; 2022 Dec; 102(12):1367-1376. PubMed ID: 36180571
[TBL] [Abstract][Full Text] [Related]
18. Estrogen-related receptor-α promotes gallbladder cancer development by enhancing the transcription of Nectin-4.
Wang L; Yang M; Guo X; Yang Z; Liu S; Ji Y; Jin H
Cancer Sci; 2020 May; 111(5):1514-1527. PubMed ID: 32030850
[TBL] [Abstract][Full Text] [Related]
19. Circular RNA FOXP1 promotes tumor progression and Warburg effect in gallbladder cancer by regulating PKLR expression.
Wang S; Zhang Y; Cai Q; Ma M; Jin LY; Weng M; Zhou D; Tang Z; Wang JD; Quan Z
Mol Cancer; 2019 Oct; 18(1):145. PubMed ID: 31623628
[TBL] [Abstract][Full Text] [Related]
20. Overexpressed microRNA-136 works as a cancer suppressor in gallbladder cancer through suppression of JNK signaling pathway via inhibition of MAP2K4.
Niu J; Li Z; Li F
Am J Physiol Gastrointest Liver Physiol; 2019 Nov; 317(5):G670-G681. PubMed ID: 31369289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
